{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T11:07:55Z","timestamp":1768648075995,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T00:00:00Z","timestamp":1554681600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00592-019-01338-1","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T04:14:22Z","timestamp":1554696862000},"page":"899-906","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Analysis of S100A12 plasma levels in hyperlipidemic subjects with or without familial hypercholesterolemia"],"prefix":"10.1007","volume":"56","author":[{"given":"Roberto","family":"Scicali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonino","family":"Di Pino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Urbano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviana","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Marchisello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Di Mauro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Scamporrino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnese","family":"Filippello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Piro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata Maria","family":"Rabuazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Purrello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"key":"1338_CR1","doi-asserted-by":"publisher","first-page":"887","DOI":"10.3109\/10641968909035380","volume":"11","author":"RJ Havel","year":"1989","unstructured":"Havel RJ (1989) Biology of cholesterol, lipoproteins and atherosclerosis. Clin Exp Hypertens Part A Theory Pract 11:887\u2013900. https:\/\/doi.org\/10.3109\/10641968909035380","journal-title":"Clin Exp Hypertens Part A Theory Pract"},{"key":"1338_CR2","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/MOL.0000000000000330","volume":"27","author":"J Bor\u00e9n","year":"2016","unstructured":"Bor\u00e9n J, Williams KJ (2016) The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity. Curr Opin Lipidol 27:473\u2013483. https:\/\/doi.org\/10.1097\/MOL.0000000000000330","journal-title":"Curr Opin Lipidol"},{"key":"1338_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","volume":"385","author":"GBD 2013 Mortality and Causes of Death Collaborators","year":"2015","unstructured":"GBD 2013 Mortality and Causes of Death Collaborators (2015) Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (London, England) 385:117\u2013171. https:\/\/doi.org\/10.1016\/S0140-6736(14)61682-2","journal-title":"Lancet (London, England)"},{"key":"1338_CR4","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"GK Hansson","year":"2005","unstructured":"Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685\u20131695. https:\/\/doi.org\/10.1056\/NEJMra043430","journal-title":"N Engl J Med"},{"key":"1338_CR5","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T et al (2017) Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 377:1119\u20131131. https:\/\/doi.org\/10.1056\/NEJMoa1707914","journal-title":"N Engl J Med"},{"key":"1338_CR6","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nri1882","volume":"6","author":"GK Hansson","year":"2006","unstructured":"Hansson GK, Libby P (2006) The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6:508\u2013519. https:\/\/doi.org\/10.1038\/nri1882","journal-title":"Nat Rev Immunol"},{"key":"1338_CR7","doi-asserted-by":"publisher","first-page":"e001403","DOI":"10.1161\/JAHA.114.001403","volume":"4","author":"RA Dijk van","year":"2015","unstructured":"van Dijk RA, Duinisveld AJF, Schaapherder AF et al (2015) A change in inflammatory footprint precedes plaque instability: a systematic evaluation of cellular aspects of the adaptive immune response in human atherosclerosis. J Am Heart Assoc 4:e001403. https:\/\/doi.org\/10.1161\/JAHA.114.001403","journal-title":"J Am Heart Assoc"},{"key":"1338_CR8","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.atherosclerosis.2017.10.003","volume":"267","author":"A Lebedeva","year":"2017","unstructured":"Lebedeva A, Vorobyeva D, Vagida M et al (2017) Ex vivo culture of human atherosclerotic plaques: a model to study immune cells in atherogenesis. Atherosclerosis 267:90\u201398. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.10.003","journal-title":"Atherosclerosis"},{"key":"1338_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.atherosclerosissup.2017.07.002","volume":"29","author":"A Pirillo","year":"2017","unstructured":"Pirillo A, Garlaschelli K, Arca M et al (2017) Spectrum of mutations in Italian patients with familial hypercholesterolemia: new results from the LIPIGEN study. Atheroscler Suppl 29:17\u201324. https:\/\/doi.org\/10.1016\/j.atherosclerosissup.2017.07.002","journal-title":"Atheroscler Suppl"},{"key":"1338_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.atherosclerosissup.2017.07.001","volume":"29","author":"M Averna","year":"2017","unstructured":"Averna M, Cefal\u00f9 AB, Casula M et al (2017) Familial hypercholesterolemia: the Italian atherosclerosis society network (LIPIGEN). Atheroscler Suppl 29:11\u201316. https:\/\/doi.org\/10.1016\/j.atherosclerosissup.2017.07.001","journal-title":"Atheroscler Suppl"},{"key":"1338_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2007.07.025","volume":"196","author":"G Basta","year":"2008","unstructured":"Basta G (2008) Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications. Atherosclerosis 196:9\u201321. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2007.07.025","journal-title":"Atherosclerosis"},{"key":"1338_CR12","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1365-2362.2010.02298.x","volume":"40","author":"H Koyama","year":"2010","unstructured":"Koyama H, Nishizawa Y (2010) AGEs\/RAGE in CKD: irreversible metabolic memory road toward CVD? Eur J Clin Investig 40:623\u2013635. https:\/\/doi.org\/10.1111\/j.1365-2362.2010.02298.x","journal-title":"Eur J Clin Investig"},{"key":"1338_CR13","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0092-8674(00)80801-6","volume":"97","author":"MA Hofmann","year":"1999","unstructured":"Hofmann MA, Drury S, Fu C et al (1999) RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100\/calgranulin polypeptides. Cell 97:889\u2013901","journal-title":"Cell"},{"key":"1338_CR14","first-page":"92","volume":"1","author":"MA Hofmann Bowman","year":"2011","unstructured":"Hofmann Bowman MA, Schmidt AM (2011) S100\/calgranulins EN-RAGEing the blood vessels: implications for inflammatory responses and atherosclerosis. Am J Cardiovasc Dis 1:92\u2013100","journal-title":"Am J Cardiovasc Dis"},{"key":"1338_CR15","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1189\/jlb.69.6.986","volume":"69","author":"Z Yang","year":"2001","unstructured":"Yang Z, Tao T, Raftery MJ et al (2001) Proinflammatory properties of the human S100 protein S100A12. J Leukoc Biol 69:986\u2013994","journal-title":"J Leukoc Biol"},{"key":"1338_CR16","doi-asserted-by":"publisher","first-page":"5423","DOI":"10.1210\/jc.2003-032223","volume":"89","author":"A Kosaki","year":"2004","unstructured":"Kosaki A, Hasegawa T, Kimura T et al (2004) Increased plasma S100A12 (EN-RAGE) levels in patients with type 2 Diabetes. J Clin Endocrinol Metab 89:5423\u20135428. https:\/\/doi.org\/10.1210\/jc.2003-032223","journal-title":"J Clin Endocrinol Metab"},{"key":"1338_CR17","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1093\/rheumatology\/keg385","volume":"42","author":"D Foell","year":"2003","unstructured":"Foell D, Kane D, Bresnihan B et al (2003) Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology 42:1383\u20131389. https:\/\/doi.org\/10.1093\/rheumatology\/keg385","journal-title":"Rheumatology"},{"key":"1338_CR18","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1159\/000324693","volume":"33","author":"J Gawdzik","year":"2011","unstructured":"Gawdzik J, Mathew L, Kim G et al (2011) Vascular remodeling and arterial calcification are directly mediated by S100A12 (EN-RAGE) in chronic kidney disease. Am J Nephrol 33:250\u2013259. https:\/\/doi.org\/10.1159\/000324693","journal-title":"Am J Nephrol"},{"key":"1338_CR19","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1042\/bj20021371","volume":"370","author":"H Yonekura","year":"2003","unstructured":"Yonekura H, Yamamoto Y, Sakurai S et al (2003) Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J 370:1097\u20131109. https:\/\/doi.org\/10.1042\/BJ20021371","journal-title":"Biochem J"},{"key":"1338_CR20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-00954","author":"A Pino Di","year":"2017","unstructured":"Di Pino A, Mangiafico S, Urbano F et al (2017) HbA < inf > 1c <\/inf > identifies subjects with prediabetes and subclinical left ventricular diastolic dysfunction. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2017-00954","journal-title":"J Clin Endocrinol Metab"},{"key":"1338_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/HCO.0000000000000179","volume":"30","author":"I Ikonomidis","year":"2015","unstructured":"Ikonomidis I, Makavos G, Lekakis J (2015) Arterial stiffness and coronary artery disease. Curr Opin Cardiol 30:1. https:\/\/doi.org\/10.1097\/HCO.0000000000000179","journal-title":"Curr Opin Cardiol"},{"key":"1338_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2017.07.003","author":"R Scicali","year":"2018","unstructured":"Scicali R, Di Pino A, Platania R et al (2018) Detecting familial hypercholesterolemia by serum lipid profile screening in a hospital setting: Clinical, genetic and atherosclerotic burden profile. Nutr Metab Cardiovasc Dis. https:\/\/doi.org\/10.1016\/j.numecd.2017.07.003","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"1338_CR23","doi-asserted-by":"publisher","first-page":"3478\u201390a","DOI":"10.1093\/eurheartj\/eht273","volume":"34","author":"BG Nordestgaard","year":"2013","unstructured":"Nordestgaard BG, Chapman MJ, Humphries SE et al (2013) Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J 34:3478\u201390a. https:\/\/doi.org\/10.1093\/eurheartj\/eht273","journal-title":"Eur Heart J"},{"key":"1338_CR24","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","volume":"63","author":"NJ Stone","year":"2014","unstructured":"Stone NJ, Robinson JG, Lichtenstein AH et al (2014) 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. J Am Coll Cardiol 63:2889\u20132934. https:\/\/doi.org\/10.1016\/j.jacc.2013.11.002","journal-title":"J Am Coll Cardiol"},{"key":"1338_CR25","doi-asserted-by":"publisher","first-page":"918368","DOI":"10.1155\/2012\/918368","volume":"2012","author":"H Ryan","year":"2012","unstructured":"Ryan H, Trosclair A, Gfroerer J (2012) Adult current smoking: differences in definitions and prevalence estimates\u2014NHIS and NSDUH, 2008. J Environ Public Health 2012:918368. https:\/\/doi.org\/10.1155\/2012\/918368","journal-title":"J Environ Public Health"},{"key":"1338_CR26","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1515\/CCLM.2007.246","volume":"45","author":"A Mosca","year":"2007","unstructured":"International Federation of Clinical Chemistry and Laboratory Medicine, IFCC Scientific Division IF of C, Mosca A, Goodall I et al (2007) Global standardization of glycated hemoglobin measurement: the position of the IFCC working group. Clin Chem Lab Med 45:1077\u20131080. https:\/\/doi.org\/10.1515\/CCLM.2007.246","journal-title":"Clin Chem Lab Med"},{"key":"1338_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2017.06.014","author":"A Pino Di","year":"2017","unstructured":"Di Pino A, Currenti W, Urbano F et al (2017) High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes. Nutr Metab Cardiovasc Dis. https:\/\/doi.org\/10.1016\/j.numecd.2017.06.014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"1338_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000148646","volume":"29","author":"Y Mori","year":"2009","unstructured":"Mori Y, Kosaki A, Kishimoto N et al (2009) Increased plasma S100A12 (EN-RAGE) levels in hemodialysis patients with atherosclerosis. Am J Nephrol 29:18\u201324. https:\/\/doi.org\/10.1159\/000148646","journal-title":"Am J Nephrol"},{"key":"1338_CR29","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1210\/jc.2015-4069","volume":"101","author":"A Pino Di","year":"2016","unstructured":"Di Pino A, Urbano F, Zagami RM et al (2016) Low endogenous secretory receptor for advanced glycation end-products levels are associated with inflammation and carotid atherosclerosis in prediabetes. J Clin Endocrinol Metab 101:1701\u20131709. https:\/\/doi.org\/10.1210\/jc.2015-4069","journal-title":"J Clin Endocrinol Metab"},{"key":"1338_CR30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.atherosclerosis.2016.11.003","volume":"255","author":"R Scicali","year":"2016","unstructured":"Scicali R, Giral P, Gallo A et al (2016) HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients. Atherosclerosis 255:102\u2013108. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.11.003","journal-title":"Atherosclerosis"},{"key":"1338_CR31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross R (1999) Atherosclerosis\u2014an inflammatory disease. N Engl J Med 340:115\u2013126. https:\/\/doi.org\/10.1056\/NEJM199901143400207","journal-title":"N Engl J Med"},{"key":"1338_CR32","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/cvr\/cvt206","volume":"100","author":"S Menini","year":"2013","unstructured":"Menini S, Iacobini C, Ricci C et al (2013) The galectin-3\/RAGE dyad modulates vascular osteogenesis in atherosclerosis. Cardiovasc Res 100:472\u2013480. https:\/\/doi.org\/10.1093\/cvr\/cvt206","journal-title":"Cardiovasc Res"},{"key":"1338_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.26466","author":"H Mollazadeh","year":"2018","unstructured":"Mollazadeh H, Carbone F, Montecucco F et al (2018) Oxidative burden in familial hypercholesterolemia. J Cell Physiol. https:\/\/doi.org\/10.1002\/jcp.26466","journal-title":"J Cell Physiol"},{"key":"1338_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-017-1089-4","author":"R Scicali","year":"2018","unstructured":"Scicali R, Di Pino A, Ferrara V et al (2018) New treatment options for lipid-lowering therapy in subjects with type 2 diabetes. Acta Diabetol. https:\/\/doi.org\/10.1007\/s00592-017-1089-4","journal-title":"Acta Diabetol"},{"key":"1338_CR35","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1210\/jc.2012-1563","volume":"97","author":"M Benn","year":"2012","unstructured":"Benn M, Watts GF, Tybjaerg-Hansen A, Nordestgaard BG (2012) Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J Clin Endocrinol Metab 97:3956\u20133964. https:\/\/doi.org\/10.1210\/jc.2012-1563","journal-title":"J Clin Endocrinol Metab"},{"key":"1338_CR36","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1161\/ATVBAHA.114.304306","volume":"34","author":"S Ligthart","year":"2014","unstructured":"Ligthart S, Sedaghat S, Ikram MA et al (2014) EN-RAGE: a novel inflammatory marker for incident coronary heart disease. Arterioscler Thromb Vasc Biol 34:2695\u20132699. https:\/\/doi.org\/10.1161\/ATVBAHA.114.304306","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1338_CR37","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1007\/s00125-018-4641-z","volume":"61","author":"C Nowak","year":"2018","unstructured":"Nowak C, Carlsson AC, \u00d6stgren CJ et al (2018) Multiplex proteomics for prediction of major cardiovascular events in type 2 diabetes. Diabetologia 61:1748\u20131757. https:\/\/doi.org\/10.1007\/s00125-018-4641-z","journal-title":"Diabetologia"},{"key":"1338_CR38","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.2337\/dc13-2357","volume":"37","author":"A Pino Di","year":"2014","unstructured":"Di Pino A, Scicali R, Calanna S et al (2014) Cardiovascular risk profile in subjects with prediabetes and new-onset type 2 diabetes identified by HbA1c according to american diabetes association criteria. Diabetes Care 37:1447\u20131453. https:\/\/doi.org\/10.2337\/dc13-2357","journal-title":"Diabetes Care"},{"key":"1338_CR39","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1194\/jlr.M038968","volume":"54","author":"P Quade-Lyssy","year":"2013","unstructured":"Quade-Lyssy P, Kanarek AM, Baiersd\u00f6rfer M et al (2013) Statins stimulate the production of a soluble form of the receptor for advanced glycation end products. J Lipid Res 54:3052\u20133061. https:\/\/doi.org\/10.1194\/jlr.M038968","journal-title":"J Lipid Res"},{"key":"1338_CR40","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/S0140-6736(09)60447-5","volume":"373","author":"PM Ridker","year":"2009","unstructured":"Ridker PM, Danielson E, Fonseca FA et al (2009) Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet (London, England) 373:1175\u20131182. https:\/\/doi.org\/10.1016\/S0140-6736(09)60447-5","journal-title":"Lancet (London, England)"},{"key":"1338_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-018-1144-9","author":"R Scicali","year":"2018","unstructured":"Scicali R, Rosenbaum D, Di Pino A et al (2018) An increased waist-to-hip ratio is a key determinant of atherosclerotic burden in overweight subjects. Acta Diabetol. https:\/\/doi.org\/10.1007\/s00592-018-1144-9","journal-title":"Acta Diabetol"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-019-01338-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-019-01338-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-019-01338-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T13:38:01Z","timestamp":1694785081000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-019-01338-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["1338"],"URL":"https:\/\/doi.org\/10.1007\/s00592-019-01338-1","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,8]]},"assertion":[{"value":"2 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study has been approved by the local ethic committee in accordance with the ethical standards of the institutional and national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from each participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}